中国碳青霉烯耐药肺炎克雷伯菌ST11新亚克隆:毒力与传播力增强
研究收集2013-2017年中国某三级医院203株引起血流感染的碳青霉烯耐药肺炎克雷伯菌(CRKP),发现优势克隆ST11中KL47自2016年起被KL64替代。ST11-KL64感染者30天死亡率显著更高,表型试验证实毒力增强,系统发育重建显示其由ST11-KL47样祖先进化而来,并鉴定出携带rmpA和peg-344的pLVPK样毒力质粒。
要点
- ST11-KL64 CRKP感染者30天死亡率显著高于其他CRKP感染者。
- ST11-KL64由ST11-KL47样祖先进化而来,自2016年起检出pLVPK样毒力质粒。
- pLVPK样阳性的ST11-KL64环境存活能力增强,需靶向监测。
核心结论
- ST11-KL64是自2016年起出现的CRKP新亚克隆,具有增强的毒力和传播力,需紧急靶向监测。
研究设计与样本
- 研究收集2013-2017年中国某三级医院203株引起血流感染的CRKP,并进行表型试验、系统发育重建和全国性回顾性筛查。
主要发现
- ST11-KL64 CRKP感染者30天死亡率显著高于其他CRKP感染者。
- ST11-KL64自2016年起独家携带pLVPK样毒力质粒(含rmpA和peg-344)。
- pLVPK样阳性的ST11-KL64分离株环境存活能力增强。
- 全国性回顾性筛查在多个地区鉴定出ST11-KL64。
关键数值与推荐
- ST11-KL64由ST11-KL47样祖先通过重组衍生而来。
临床怎么用
- 对ST11-KL64 CRKP进行靶向监测,以控制其传播。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
We aimed to clarify the epidemiologic and clinical importance of evolutionary events that occurred in carbapenem-resistant Klebsiella pneumoniae (CRKP). We collected 203 CRKP causing bloodstream infections in a tertiary hospital in China during 2013-2017. We detected a subclonal shift in the dominant clone sequence type (ST) 11 CRKP in which the previously prevalent capsular loci (KL) 47 had been replaced by KL64 since 2016. Patients infected with ST11-KL64 CRKP had a significantly higher 30-day mortality rate than other CRKP-infected patients. Enhanced virulence was further evidenced by phenotypic tests. Phylogenetic reconstruction demonstrated that ST11-KL64 is derived from an ST11-KL47-like ancestor through recombination. We identified a pLVPK-like virulence plasmid carrying rmpA and peg-344 in ST11-KL64 exclusively from 2016 onward. The pLVPK-like-positive ST11-KL64 isolates exhibited enhanced environmental survival. Retrospective screening of a national collection identified ST11-KL64 in multiple regions. Targeted surveillance of this high-risk CRKP clone is urgently needed.
引用
- Zhou K, Xiao T, David S, et al. Novel Subclone of Carbapenem-Resistant Klebsiella pneumoniae Sequence Type 11 with Enhanced Virulence and Transmissibility, China. Emerg Infect Dis. 2020. PMID: 31961299. doi:10.3201/eid2602.190594
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。